FDA Approves Gardasil 9 HPV Vaccine
The US Food and Drug Administration (FDA) has approved Gardasil 9, a new vaccine for human papillomavirus (HPV). The vaccine is expected to become available in February 2015.
Who Should Get the HPV Vaccination and Why
Human papillomavirus (HPV) is the most common sexually transmitted infection in the US according to the Centers for Disease Control and Prevention (CDC).
What You Need to Know About Testing for Cervical Cancer
During the past several decades, screening – testing for cancer before symptoms develop – has reduced deaths from cervical cancer, as doctors have been able to find cancer early and treat it, or prevent it from ever developing.
CDC: Millions of Women Not Getting Cervical Cancer Tests
A new report from the US Centers for Disease Control and Prevention (CDC) finds that 8 million women who should be getting screening tests for cervical cancer are not getting them.
FDA Approves Avastin for Advanced Cervical Cancer
The US Food and Drug Administration (FDA) has approved a new use for the targeted therapy drug, Avastin (bevacizumab). The new use is for cervical cancer that has not improved with treatment, has come back after treatment, or has spread to other parts of the body.
A Shot at a Healthy School Year
As the new school year begins and students head back to the classroom, be sure they’re up to date with vaccinations.
FDA Approves HPV Test as First Line Screening for Cervical Cancer
The US Food and Drug Administration (FDA) has for the first time approved a human papilloma virus (HPV) test that can be used alone instead of the Pap test to screen for cervical cancer.
Why We Screen for Some Cancers and Not Others
Screening means having a test that looks for cancer or another disease in people who don’t have any symptoms.
President’s Cancer Panel: Efforts Needed to Increase HPV Vaccination Rates
The President's Cancer Panel has released a report calling for a coordinated effort to increase the rates of vaccinations against human papillomavirus (HPV).
Lower HPV Rates in Teen Girls Attributed to Vaccine
Researchers from the CDC are reporting a 56% drop in human papillomavirus (HPV) infections in girls and young women since the HPV vaccine was introduced in the US.
Study Compares 2 Doses of HPV Vaccine to 3
Canadian researchers are studying whether 2 doses of the human papilloma virus (HPV) vaccine are as effective as the complete 3-dose series.
Cervical Cancer: Testing Can Find it Early and Even Prevent It
During the past few decades, screening has reduced deaths from cervical cancer, as doctors have been able to find cancer early and treat it, or prevent it from ever developing.
Cancer Can Be Treated During Pregnancy
When a pregnant woman is diagnosed with cancer, her treatment decisions are complicated by concern about how treatment may affect the baby’s health.
Significant Proportion of Cancer Caused By Infection
New Screening Guidelines for Cervical Cancer
The American Cancer Society today released new screening recommendations for the prevention and early detection of cervical cancer.
Women Don’t Get the Help They Want for Sexual Problems After Cancer Treatment
Many women with breast or gynecological cancer want medical help for sexual problems after their treatment but aren’t getting it, researchers say.
New Report to Lead to Revised Cervical Cancer Screening Guidelines
A report prepared for the U.S. Preventive Services Task Force (USPSTF) finds that a newer method of Pap testing is just as effective as the conventional method.
Study: Cervical Cancer Risk Lower in IUD Users
A new study contradicts a widespread assumption that using an intrauterine device (IUD) increases the risk of cervical cancer.
ACOG Revises Cervical Cancer Screening Guidelines
The American College of Obstetricians and Gynecologists (ACOG) is now recommending women begin cervical cancer screening at age 21, instead of 3 years after the onset of sexual activity, as was previously recommended by the group.
FDA Approves Second HPV Vaccine
The Food and Drug Administration (FDA) recently green-lighted Cervarix, the second vaccine designed to prevent infections caused by the human papilloma virus (HPV), a serious risk factor for cervical cancer.
Nobel Prize for Discovery of Cervical Cancer Virus
A German scientist has won the Nobel Prize in Medicine, for his discoveries about the family of viruses that cause cervical cancer.